Michael R. Jaff spends much of his time researching Surgery, Angioplasty, Internal medicine, Revascularization and Cardiology. His study brings together the fields of Radiology and Surgery. His work carried out in the field of Angioplasty brings together such families of science as Endarterectomy, Stenosis, Popliteal artery, Claudication and Atherectomy.
Many of his research projects under Internal medicine are closely connected to Foundation with Foundation, tying the diverse disciplines of science together. His study looks at the relationship between Revascularization and topics such as Renal artery, which overlap with Renal function and Blood pressure. In his research, Renal replacement therapy is intimately related to Kidney disease, which falls under the overarching field of Cardiology.
Surgery, Internal medicine, Cardiology, Radiology and Revascularization are his primary areas of study. Surgery is closely attributed to Angioplasty in his work. The various areas that he examines in his Angioplasty study include Intermittent claudication, Popliteal artery, Prospective cohort study, Balloon and Claudication.
His biological study spans a wide range of topics, including Peripheral and Blood pressure. Michael R. Jaff studies Critical limb ischemia, a branch of Revascularization. His Pulmonary embolism research includes elements of Thrombosis, Inferior vena cava, Thrombolysis and Intensive care medicine.
His primary areas of investigation include Surgery, Internal medicine, Revascularization, Randomized controlled trial and Pulmonary embolism. Many of his studies involve connections with topics such as Angioplasty and Surgery. As a part of the same scientific family, Michael R. Jaff mostly works in the field of Internal medicine, focusing on Cardiology and, on occasion, Arterial disease and Asymptomatic.
His studies in Revascularization integrate themes in fields like Clinical endpoint, Significant difference and Amputation. Michael R. Jaff works mostly in the field of Randomized controlled trial, limiting it down to topics relating to Drug coated balloon and, in certain cases, Paclitaxel. His Pulmonary embolism study incorporates themes from Thrombolysis, Mortality rate, Venous thromboembolism, Intensive care medicine and Vascular disease.
The scientist’s investigation covers issues in Surgery, Internal medicine, Randomized controlled trial, Pulmonary embolism and Balloon. His research on Surgery frequently connects to adjacent areas such as Mechanical Thrombolysis. His study in Internal medicine is interdisciplinary in nature, drawing from both Catheter, Chi-square test and Cardiology.
His Randomized controlled trial research incorporates elements of Drug coated balloon and Angioplasty. His studies deal with areas such as Percutaneous and Revascularization as well as Balloon. His Revascularization study combines topics from a wide range of disciplines, such as Stent and Amputation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
Jay S. Yadav;Mark H. Wholey;Richard E. Kuntz;Pierre B Fayad.
The New England Journal of Medicine (2004)
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension A Scientific Statement From the American Heart Association
Michael R. Jaff;M. Sean McMurtry;Stephen L. Archer;Mary Cushman.
Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006.
P.-J. Touboul;M.G. Hennerici;S. Meairs;H. Adams.
Cerebrovascular Diseases (2007)
Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004-2006-2011). An Update on Behalf of the Advisory Board of the 3rd, 4th and 5th Watching the Risk Symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011.
P.-J. Touboul;M.G. Hennerici;S. Meairs;H. Adams.
Cerebrovascular Diseases (2012)
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Thom W. Rooke;Alan T. Hirsch;Sanjay Misra;Anton N. Sidawy.
Stenting and medical therapy for atherosclerotic renal-artery stenosis
Christopher J. Cooper;Timothy P. Murphy;Donald E. Cutlip;Kenneth Jamerson.
The New England Journal of Medicine (2014)
Nitinol Stent Implantation Versus Balloon Angioplasty for Lesions in the Superficial Femoral Artery and Proximal Popliteal Artery Twelve-Month Results From the RESILIENT Randomized Trial
John R. Laird;Barry T. Katzen;Dierk Scheinert;Johannes Lammer.
Circulation-cardiovascular Interventions (2010)
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)
Karen A. Hicks;James E. Tcheng;Biykem Bozkurt;Bernard R. Chaitman.
A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.
Gregory Piazza;Benjamin Hohlfelder;Michael R. Jaff;Kenneth Ouriel.
Jacc-cardiovascular Interventions (2015)
Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage: A Meta-analysis
Saurav Chatterjee;Anasua Chakraborty;Ido Weinberg;Mitul Kadakia.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: